Shares of small molecular diagnostics company Biocept, Inc. (NASDAQ: BIOC) are plummeting today, down 21.5% as of 11:53 a.m. EDT, following its announcement of a proposed rights offering. The decline ...

SAN DIEGO, May 14, 2020 /PRNewswire/ -- Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of molecular technologies designed to provide physicians with clinically actionable information to ...

SAN DIEGO, March 18, 2020 /PRNewswire/ -- Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to ...

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Biocept, Inc. (BIOC) one of those stocks right now? A quick ...

SAN DIEGO--(BUSINESS WIRE)--Biocept, Inc. announced today that it has appointed Michael W. Nall as President and Chief Executive Officer. Mr. Nall’s extensive commercialization, sales and marketing ...

SAN DIEGO, July 28, 2011 /PRNewswire/ -- Biocept, Inc., an advanced diagnostic CLIA-certified service laboratory developing novel tests for the oncology community, today announced the availability of ...

A public-private collaboration between the University of Minnesota and San Diego-based diagnostics firm Biocept Inc. has produced some encouraging early results in fighting testicular cancer. Biocept ...

About Biocept Biocept, Inc. develops and commercializes molecular diagnostic assays that provide physicians with clinically actionable information for treating and monitoring patients diagnosed with a ...

If you want to know who really controls Biocept Inc (NASDAQ:BIOC), then you’ll have to look at the makeup of its share registry. Institutions will often hold stock in bigger companies, and we expect ...

A Chapter 7 bankruptcy discharge absolves the company from the legal obligation to repay most unsecured debts. Last month, Biocept signed a deal with Plus Therapeutics Inc. Get the data-driven signals ...